The report "Oncology Biosimilars Market By Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others) By Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, and Others) - Global Forecasts to 2030"
The global oncology biosimilars market is projected to reach USD 3.5 billion in 2023, registering at a Compound Annual Growth Rate (CAGR)...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian